The ability to edit the genetic code of a human being in vivo may have once seemed a far-off fantasy. But the advent of CRISPR-Cas9 gene-editing technology, which saw Jennifer Doudna and Emmanuelle Charpentier win the 2020 Nobel Prize in Chemistry, has made it very much a reality.